CDT EQUITY LTD
Company number 13885643 · Active · London EC1A 9ET
CDT EQUITY LTD is an active private limited company (company number 13885643) incorporated on 1 February 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£3.70m and cash of £100k, with 5 employees on average. Net assets fell 405% on the prior period (−£732k).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 1 February 2022
- Next accounts due
- 30 September 2026 — 18 days overdue
- Confirmation statement due
- 15 February 2027 — in 120 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 December 2024
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£3.70m | £100k | — | £4.11m | — | — | 5 |
| 31 December 2023 | −£732k | £254k | — | £1.02m | — | — | 3 |
- Current ratio
- 0.06 — current liabilities exceed current assets
- Cash per employee
- £20k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 17/100 (grade E)
- -15 Negative net assets — Net assets £-3,697,845 at 2024-12-31
- -8 Net assets falling — -405.0% vs prior period
- -8 Current liabilities exceed current assets — Current ratio 0.06
- +4 Cash reserves — Cash £99,682
- +4 Past first filings — Incorporated 2022-02-01
- -10 Accounts overdue — Due 2026-09-30
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Cdt Equity Inc. (corporate entity, United States) — owns 75–100% of shares; holds 75–100% of voting rights · since 8 December 2025
- Mr James Bligh — owns 75–100% of shares; can appoint or remove directors; can appoint or remove directors; can appoint or remove directors · since 1 February 2022 · ceased 8 December 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- QUANTICO MRI LIMITED — London, inc. Feb 2022
- BIOMINIONS LTD — London, inc. Feb 2022
- TIGERMED UK LTD — London, inc. Jan 2022
- OCUS INNOVATION (UK) LIMITED — London, inc. Feb 2022
- ANTIBODY DESIGN LTD — London, inc. Feb 2022
- WOOST LTD — London, inc. Feb 2022
Reminders for CDT EQUITY LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.